Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease.

1D1 , *P < 0.05), verified by linear regression showing a highly significant placebo effect, in the low placebo dose female group Fig. 2D2 , **P < 0.01), like the trending in the male group (Fig. 2A2 ).

also in 23,678 other papers

2C1 with male placebo groups and davunetide 5 mg showing a significant low-dose placebo effect (*P < 0.02), while male placebo groups and davunetide 15 mg showed a trend in intercept difference, indicative of a trend in davunetide effect (Fig. 2C2 , #P = 0.1108).

also in 11,799 other papers

Here, as in the digit span forward test, a limited trend toward significance was observed for the high-dose group (Fig. 3C2 , #P = 0.1324).

also in 54 other papers